MercyOne back online after ransomware attack

MercyOne Central Iowa is mostly back online in the aftermath of a ransomware attack of its parent company, CommonSpirit Health.

The Des Moines-based Catholic medical group, which is part of the MercyOne health system, announced that all its hospital and clinic systems, payroll platform and patient records are back online. 

The medical group noted it is still dealing with some issues stemming from the cybersecurity breach, though it is still providing high quality care to its patients, it said. Patients are currently not able to schedule appointments online in Central Iowa.

“Patients can be assured that MercyOne is able to serve all health care needs with some disruption to normal operations,” the group said Nov. 1.

MercyOne also offered footage of how the health system has had to pull together to address the cybersecurity attack and still care for its patients. 

CommonSpirit Health is one of the largest health systems in the United States and the second-largest nonprofit hospital chain, operating 142 hospitals and more than 2,200 care centers across 21 states. The cyberattack impacted electronic health records (EHRs), which were taken offline, as well as patient portals.

The attack comes as healthcare organizations are one the top industries being targeted by cybercriminals due to the vast amount of high-value, personal information they hold. Healthcare data breaches are extremely expensive, costing an average of $10 million, according to one recent study. In addition, healthcare breaches can impact how patients feel about their healthcare organizations and lose trust.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.